Mack Hicks was appointed Director of Beneficient, effective March 10, 2026. As of November 14, 2026, Beneficient has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 12, 2026 to June 25, 2026, naming 1 appointment (Form 8-K, March 12, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Beneficient? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Beneficient reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-12 to 2026-06-25. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Beneficient files it.
Also on the record for Beneficient
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 5, 2026 | Stake report, Schedule 13G/A, by YA II PN, Ltd. | — | 5%+ stakes | Source |
| July 9, 2026 | Stake report, Schedule 13D, by James G. Silk | 7.5% of the class | 5%+ stakes | Source |
| April 20, 2026 | Stake report, Schedule 13D/A, by Mack Hicks | 81.2% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Hatteras Investment Partners, LP | — | 5%+ stakes | Source |
| August 19, 2025 | Stake report, Schedule 13G/A, by Hatteras Investment Partners, LP | 6.7% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Beneficient now and the warning signs.
Free to see. No signup.
Keep reading
More on Beneficient and the records around it.
Beneficient elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- YA II PN, Ltd. also filed stake reports on 14 other companies: Ives Ultra AI Opportunities Inc. (Oct 2026), Optimi Health Corp. (Oct 2026), PRF Technologies Ltd. (Jun 2026)
Watch Beneficient
Get an email when Beneficient files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Beneficient?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Beneficient: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Beneficient covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-25 | Reported | not named in the filing | 8-K/A, 2026-06-25 | ||
| 2026-03-12 | In | Director | 2026-03-10 | 8-K, 2026-03-12 |
Who leads Beneficient, as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Mack Hicks, appointed, effective 2026-03-10 (filed 2026-03-12).
New leaders reset buying decisions — get the Full Report on Beneficient: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Beneficient, with the record behind each one.
Find candidates like Director at BeneficientEvery change, in the filing's words
Reported
Effective June 22, 2026, the Board appointed Mr. Hicks to the Executive Committee and the Nominating Committee of the Board.
Appointed: Mack Hicks, Director, effective 2026-03-10
Effective March 10, 2026, the Board appointed Mack Hicks to serve as a director of the Company.
- Mr. Hicks is currently Chief Executive Officer of Hicks Holdings LLC, a single-family office with an operating private equity and real estate investment businesses and has been with the firm since 2007.
- Mr. Hicks is the Co-Founder of Accresa Health, a payment technology company focused on healthcare, and has served as a partner at Accresa since 2015.
- Prior to his involvement with Hicks Holdings, Mr. Hicks was a research analyst at Halcyon Asset Management LLC, a multi-strategy hedge fund where he was involved in investments in fixed income securities and in public and private equity transactions.
- Prior to that, he worked at Credit Suisse First Boston as an analyst in the Financial Sponsors and Leverage Finance Groups.
- Mr. Hicks previously served on the board of Sight Sciences, Inc. (Nasdaq: SGHT), an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases, from 2011 to 2023.
- Mr. Hicks received his B.A. in History from the University of Texas at Austin, and is a graduate of the Owner/President Management Program at the Harvard Business School of Executive Education.
- As of the date of this filing, Mr. Hicks has not been appointed to any committees of the Board, and the terms of Mr. Hicks's compensation for serving on the Board have not been determined.
Tools for this story
Each opens in a new tab, filled in for Beneficient. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
